Cart
sales@molnova.com
DGY-06-116
CAS No. ——
DGY-06-116( —— )
Catalog No. M22645 CAS No. ——
DGY-06-116 is an selective and irreversible covalent inhibitor of Src and FGFR1 with IC50 value of 3nM and 8340 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 165 | In Stock |
|
| 5MG | 235 | In Stock |
|
| 10MG | 393 | In Stock |
|
| 25MG | 657 | In Stock |
|
| 50MG | 1007 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDGY-06-116
-
NoteResearch use only, not for human use.
-
Brief DescriptionDGY-06-116 is an selective and irreversible covalent inhibitor of Src and FGFR1 with IC50 value of 3nM and 8340 nM, respectively.
-
DescriptionDGY-06-116 is an selective and irreversible covalent inhibitor of Src and FGFR1 with IC50 value of 3nM and 8340 nM, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetSrc
-
RecptorSrc|FGFR1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight597.11
-
Molecular FormulaC32H33ClN8O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (167.47 mM)
-
SMILESCN1CCN(CC1)c1ccc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)c(Nc3ccccc3NC(=O)C=C)n2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gurbani D , Du G , Henning N J , et al. Structure and Characterization of a Covalent Inhibitor of Src Kinase[J]. Frontiers in Molecular Bioences, 2020, 7:81.
molnova catalog
related products
-
P7C3-A20
P7C3 is a drug related to latrepirdine (dimebon), which has neuroprotective and proneurogenic effects, and may be potentially useful for the treatment of Alzheimer's disease and similar neurodegenerative disorders.
-
7-Hydroxy-4-chromone
7-Hydroxychromone is a Src kinase inhibitor (IC50 of <300 μM).
-
Lyn peptide inhibito...
Cell-permeable inhibitor of Lyn-dependent effects of the IL-5 receptor. Blocks binding of Lyn tyrosine kinase to βc subunit of IL-3/GM-CSF/IL-5 receptors, blocking Lyn activation. Inhibits IL-5 receptor-mediated eosinophil differentiation and survival in vitro. Inhibits airway eosinophilic inflammation in mouse model of asthma.
